ES2247736T3 - Microparticulas para el transporte de sustancias farmaceuticas a traves de la mucosa y la barrera hematoencefalica. - Google Patents

Microparticulas para el transporte de sustancias farmaceuticas a traves de la mucosa y la barrera hematoencefalica.

Info

Publication number
ES2247736T3
ES2247736T3 ES98965704T ES98965704T ES2247736T3 ES 2247736 T3 ES2247736 T3 ES 2247736T3 ES 98965704 T ES98965704 T ES 98965704T ES 98965704 T ES98965704 T ES 98965704T ES 2247736 T3 ES2247736 T3 ES 2247736T3
Authority
ES
Spain
Prior art keywords
microparticles
mucosa
transport
water
pharmaceutical substances
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES98965704T
Other languages
English (en)
Inventor
Maria Rosa Gasco
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Application granted granted Critical
Publication of ES2247736T3 publication Critical patent/ES2247736T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7028—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages
    • A61K31/7034—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a carbocyclic compound, e.g. phloridzin
    • A61K31/7036—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a carbocyclic compound, e.g. phloridzin having at least one amino group directly attached to the carbocyclic ring, e.g. streptomycin, gentamycin, amikacin, validamycin, fortimicins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A61K38/23—Calcitonins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/19—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles lyophilised, i.e. freeze-dried, solutions or dispersions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/51—Nanocapsules; Nanoparticles
    • A61K9/5107—Excipients; Inactive ingredients
    • A61K9/5123—Organic compounds, e.g. fats, sugars
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S977/00—Nanotechnology
    • Y10S977/902—Specified use of nanostructure
    • Y10S977/904—Specified use of nanostructure for medical, immunological, body treatment, or diagnosis
    • Y10S977/924—Specified use of nanostructure for medical, immunological, body treatment, or diagnosis using nanostructure as support of dna analysis

Abstract

Utilización de micropartículas compuestas de un lípido o varios lípidos y una sustancia farmacéutica seleccionada de entre péptidos, antibióticos, citoestáticos para el tratamiento de linfomas, y, opcionalmente, de un agente estabilizante seleccionado de entre el grupo formado por dipalmitoilfosfatidiletanolamina-PEG, PEG- estearato, esteres de ácidos grasos de ácido mirístico hasta ácido docosanoico con metiléter-PEG, diacilfosfatidiletanolaminas esterificadas con metiléter-PEG, y polilactatos y lactatos poliglicólicos esterificados con metiléter-PEG, para la preparación de composiciones apropiadas para ser administradas por vía oral para la absorción transmucosa de citoestáticos utilizados para el tratamiento de linfomas, y de antibióticos y péptidos con efectos sobre el sistema linfático.
ES98965704T 1997-12-01 1998-11-27 Microparticulas para el transporte de sustancias farmaceuticas a traves de la mucosa y la barrera hematoencefalica. Expired - Lifetime ES2247736T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT97MI002663A IT1296914B1 (it) 1997-12-01 1997-12-01 Composizione farmaceutica comprendente microparticelle atte al passaggio transmucosale ed al superamento della barriera

Publications (1)

Publication Number Publication Date
ES2247736T3 true ES2247736T3 (es) 2006-03-01

Family

ID=11378297

Family Applications (1)

Application Number Title Priority Date Filing Date
ES98965704T Expired - Lifetime ES2247736T3 (es) 1997-12-01 1998-11-27 Microparticulas para el transporte de sustancias farmaceuticas a traves de la mucosa y la barrera hematoencefalica.

Country Status (8)

Country Link
US (1) US6419949B1 (es)
EP (1) EP1071408B1 (es)
AT (1) ATE303799T1 (es)
AU (1) AU2155199A (es)
DE (1) DE69831511T2 (es)
ES (1) ES2247736T3 (es)
IT (1) IT1296914B1 (es)
WO (1) WO1999027918A1 (es)

Families Citing this family (34)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1296914B1 (it) 1997-12-01 1999-08-03 Maria Rosa Gasco Composizione farmaceutica comprendente microparticelle atte al passaggio transmucosale ed al superamento della barriera
US7153525B1 (en) 2000-03-22 2006-12-26 The University Of Kentucky Research Foundation Microemulsions as precursors to solid nanoparticles
AU784191B2 (en) * 2000-04-11 2006-02-16 Ibergesfer, S.L. Structure for a washbasin
EP1345597B1 (en) * 2000-12-27 2007-10-03 Ares Trading S.A. Amphiphilic lipid nanoparticles for peptide and/or protein incorporation
US7763663B2 (en) 2001-12-19 2010-07-27 University Of Massachusetts Polysaccharide-containing block copolymer particles and uses thereof
NZ534377A (en) * 2002-03-13 2008-04-30 Collagenex Pharm Inc Water-based topical delivery system consisting of cholesterol, fatty acids water and a phospholipid/ceramide portion.
JP2006518701A (ja) * 2002-05-24 2006-08-17 ネオファーム、インコーポレイティッド カルジオリピン組成物、その製造方法及び使用
EA200401565A1 (ru) * 2002-05-24 2005-04-28 Неофарм, Инк. Способ получения кардиолипина или аналога кардиолипина (варианты), способ получения липосомы и композиция кардиолипина для лечения заболеваний (варианты)
US20050277611A1 (en) * 2002-10-16 2005-12-15 Neopharm, Inc. Cationic cardiolipin analoges and its use thereof
ITMI20022323A1 (it) * 2002-10-31 2004-05-01 Maria Rosa Gasco Composizioni farmaceutiche atte al trattamento di malattie oftalmiche.
US20050101605A1 (en) * 2003-11-07 2005-05-12 Ahmed Salah U. Oral liquid formulations of methotrexate
US20070219131A1 (en) * 2004-04-15 2007-09-20 Ben-Sasson Shmuel A Compositions capable of facilitating penetration across a biological barrier
WO2006097793A2 (en) * 2004-04-15 2006-09-21 Chiasma, Ltd. Compositions capable of facilitating penetration across a biological barrier
ITMI20041151A1 (it) * 2004-06-09 2004-09-09 Maria Rosa Gasco Nanoparticelle lipidiche come agenti veicolanti per acidi nucleici procedimento per la loro preparazione e loro uso
US20090180964A1 (en) * 2005-06-24 2009-07-16 Rao Papineni Transmucosal delivery of optical, spect, multimodal,drug or biological cargo laden nanoparticle(s) in small animals or humans
US9486408B2 (en) 2005-12-01 2016-11-08 University Of Massachusetts Lowell Botulinum nanoemulsions
US20070154403A1 (en) * 2006-01-05 2007-07-05 Thomas Skold Oral, Pulmonary and Transmucosal Delivery Composition
US7914988B1 (en) * 2006-03-31 2011-03-29 Illumina, Inc. Gene expression profiles to predict relapse of prostate cancer
EP1867323A1 (en) * 2006-06-13 2007-12-19 Farmatron Ltd. Pharmaceutical compositions with biological barriers permeation enhancing properties
CA2687106A1 (en) * 2007-05-16 2008-11-20 Yeda Research And Development Co. Ltd. Assessment of blood-brain barrier disruption
WO2009105792A1 (en) * 2008-02-18 2009-08-27 Csir Nanoparticle carriers for drug administration and process for producing same
EP2123262A1 (en) 2008-05-20 2009-11-25 Consorzio per il Centro di Biomedica Moleculare Scrl Polyelectrolyte-encapsulated gold nanoparticles capable of crossing blood-brain barrier
CA2730760A1 (en) * 2008-07-16 2010-01-21 Surmodics Pharmaceuticals, Inc. Process for preparing microparticles containing bioactive peptides
CA2963659C (en) 2008-09-17 2020-06-23 Chiasma Inc. Use of oral octreotride compositions
JP2013502263A (ja) 2009-08-18 2013-01-24 ベン‐グリオン ユニバーシティ オブ ザ ネゲヴ リサーチ アンド デベロップメント オーソリティ 撮像データを解析するためのシステムおよび方法
US10275680B2 (en) 2011-10-19 2019-04-30 Tel Hashomer Medical Research Infrastructure And Services Ltd. Magnetic resonance maps for analyzing tissue
EP2645099A1 (en) * 2012-03-30 2013-10-02 Phares Pharmaceutical Research N.V. Biorelevant compositions
EP2988668B1 (en) 2013-04-24 2019-07-24 Tel HaShomer Medical Research Infrastructure and Services Ltd. Magnetic resonance maps for analyzing tissue
JP6091721B2 (ja) 2014-12-19 2017-03-08 積水化学工業株式会社 製剤
CN107405305B (zh) 2015-01-20 2020-12-25 泰特拉德姆集团有限责任公司 提供粘膜和皮肤屏障恢复的通用局部药物递送载体和多因子组织保湿剂
EP3253401A4 (en) 2015-02-03 2018-11-21 Chiasma Inc. Method of treating diseases
CN110198703A (zh) 2016-11-21 2019-09-03 艾里奥治疗公司 大试剂的透皮递送
EP3888635A4 (en) * 2019-01-07 2022-08-03 Pusan National University Industry-University Cooperation Foundation DRUG DELIVERY PLATFORM USING W/O/W TRIOLEIN EMULSION TO PROMOTE OPENING OF THE BLOOD-BRAIN BARRIER
US11141457B1 (en) 2020-12-28 2021-10-12 Amryt Endo, Inc. Oral octreotide therapy and contraceptive methods

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3421468A1 (de) 1984-06-08 1985-12-19 Dr. Rentschler Arzneimittel Gmbh & Co, 7958 Laupheim Lipidnanopellets als traegersystem fuer arzneimittel zur peroralen anwendung
US5250236A (en) 1991-08-05 1993-10-05 Gasco Maria R Method for producing solid lipid microspheres having a narrow size distribution
DE4131562A1 (de) * 1991-09-18 1993-03-25 Medac Klinische Spezialpraep Arzneistofftraeger aus festen lipidteilchen-feste lipidnanosphaeren (sln)
DE4327063A1 (de) 1993-08-12 1995-02-16 Kirsten Dr Westesen Ubidecarenon-Partikel mit modifizierten physikochemischen Eigenschaften
US5858398A (en) * 1994-11-03 1999-01-12 Isomed Inc. Microparticular pharmaceutical compositions
IT1292142B1 (it) * 1997-06-12 1999-01-25 Maria Rosa Gasco Composizione farmaceutica in forma di microparticelle lipidiche solide atte alla somministrazione parenterale
IT1296914B1 (it) 1997-12-01 1999-08-03 Maria Rosa Gasco Composizione farmaceutica comprendente microparticelle atte al passaggio transmucosale ed al superamento della barriera

Also Published As

Publication number Publication date
EP1071408B1 (en) 2005-09-07
WO1999027918A1 (en) 1999-06-10
AU2155199A (en) 1999-06-16
EP1071408A1 (en) 2001-01-31
DE69831511T2 (de) 2006-06-14
IT1296914B1 (it) 1999-08-03
US6419949B1 (en) 2002-07-16
ATE303799T1 (de) 2005-09-15
ITMI972663A1 (it) 1999-06-01
DE69831511D1 (de) 2005-10-13

Similar Documents

Publication Publication Date Title
ES2247736T3 (es) Microparticulas para el transporte de sustancias farmaceuticas a traves de la mucosa y la barrera hematoencefalica.
CO5170479A1 (es) Emulsion aceite en agua que comprende un agente biologicamente activo micronizado y un sistema emulsionante adecuado saturado y un mono de ester de acido acrilico. .
FR2732967B1 (fr) 1-phenylpyrazole-3-carboxamides substitues, actifs sur la neurotensine, leur preparation, les compositions pharmaceutiques en contenant
DE602005010733D1 (de) Ophthalmische emulsion mit einem immunosuppressiven mittel
DE69720759D1 (de) Gut schmeckende, fluessige, waessrige zusammensetzung fuer ein bitterschmeckendes arzneimittel
RS49764B (sr) Farmaceutski preparat za primenu na mukozu
ATE172638T1 (de) Ein neues arzneimittelabgabesystem
CA2330330A1 (en) Pharmaceutical compositions comprising an amphoteric surfactant an alkoxylated cetyl alcohol and a polar drug
ES2183750T1 (es) Composicion nutritiva.
CO5611097A2 (es) Tableta farmaceutica
CY1105026T1 (el) Συστημα χορηγησεως φαρμακου : συνθεση δια λιπο-διαλυτα φαρμακα
AR030862A1 (es) Formulaciones medicinales en aerosol
ATE292455T1 (de) Fettlösliche vitamine enthaltende zusammensetzungen
KR930001929A (ko) 안과용 조성물
EE200200483A (et) Uus iseemulgeeruv ravimi manustamise süsteem
WO1998005300A3 (en) Delivery system for pharmaceutical agents encapsulated with oils
WO2001005362A3 (de) Emulgatorfreie feindisperse systeme vom typ wasser-in-öl
RS50310B (sr) Farmaceutska kompozicija koja sadrži ciklesonid za primenu na sluzokoži
AR037131A1 (es) Formulaciones de jarabe de ribavirina
PT1178787E (pt) Composicoes farmacologicas para administracao por via oral de floroglucinol e suas preparacoes
DE60121293D1 (de) Pharmazeutische zusammensetzungen, welche steroidische strukturen enthalten, und deren verwendungen
FR2817257B1 (fr) Cyclohexyl(alkyl)-propanolamines, leur preparation et compositions pharmaceutiques en contenant
WO2000038695A3 (en) Aciclovir compositions containing dimethicone
DE60112578D1 (de) Pharmazeutische diclofenac-verbindung basierend auf vitamin e, papain und hyaluronidase
RU2003105141A (ru) Желатиновые капсулы "гатробиол-цд" на основе клатратов концентрата облепихового масла, обладающие противоязвенным действием